PUBLISHER: The Business Research Company | PRODUCT CODE: 2036069
PUBLISHER: The Business Research Company | PRODUCT CODE: 2036069
Protein stability screening platforms are systems and technologies designed to evaluate the physical and chemical stability of proteins under various conditions, such as temperature, pH, and formulation environments. These platforms identify optimal storage, formulation, and development conditions, ensuring therapeutic efficacy and shelf life, and are essential for biologics and pre-sterilized nested vial applications.
The prominent protein types of protein stability screening platforms include monoclonal antibodies, recombinant proteins, vaccines and antigens, enzymes, and others. Monoclonal antibodies are lab-produced molecules designed to bind a single target antigen for diagnostics, research, or therapeutic use. Technologies include differential scanning calorimetry, differential scanning fluorimetry, spectroscopy, chromatography, and others, with components such as instruments, consumables, software, and services. Applications include drug discovery, biopharmaceutical development, protein engineering, academic research, and others, serving pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and other end users.
Tariffs have affected the protein stability screening platforms market by increasing the cost of importing high-precision instruments, consumables, and software, impacting segments like instruments and consumables, particularly in regions such as North America and Europe. These costs have slowed adoption in pharmaceutical and biotechnology companies that rely on imported equipment. However, tariffs are encouraging local manufacturing, fostering innovation in cost-efficient platforms, and promoting diversification of sourcing strategies, ultimately supporting market resilience.
The protein stability screening platforms market research report is one of a series of new reports from The Business Research Company that provides protein stability screening platforms market statistics, including protein stability screening platforms industry global market size, regional shares, competitors with a protein stability screening platforms market share, detailed protein stability screening platforms market segments, market trends and opportunities, and any further data you may need to thrive in the protein stability screening platforms industry. This protein stability screening platforms market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The protein stability screening platforms market size has grown strongly in recent years. It will grow from $1.44 billion in 2025 to $1.58 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to rising demand for biologics, adoption of conventional stability testing methods, increasing investment in pharmaceutical r&d, growth of monoclonal antibody therapies, stringent regulatory requirements.
The protein stability screening platforms market size is expected to see strong growth in the next few years. It will grow to $2.29 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to adoption of ai-driven protein stability platforms, integration with iot-enabled lab systems, expansion of biopharmaceutical pipelines, demand for real-time monitoring, development of predictive modeling software. Major trends in the forecast period include high-throughput protein stability screening, automated formulation analysis, integration with laboratory information systems, real-time protein degradation monitoring, predictive shelf-life modeling.
The increasing adoption of personalized medicine is expected to boost the protein stability screening platforms market. Personalized medicine tailors medical treatments and healthcare decisions to an individual's genetic, molecular, and clinical profile to enhance therapeutic efficacy and safety. This growth is largely driven by advances in genomics and molecular diagnostics, which facilitate the identification of genetic variations and molecular markers that influence disease progression and drug response, supporting the creation of targeted therapies. Protein stability screening platforms are vital in personalized medicine by assessing the stability, folding, and interaction of proteins under various conditions, essential for optimizing drug and biologic design. For instance, in February 2024, the Personalized Medicine Coalition, a U.S.-based non-profit, reported that in 2023 the U.S. Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the rising adoption of personalized medicine is driving the growth of the protein stability screening platforms market.
Leading companies operating in the protein stability screening platforms market are increasingly focusing on the development of innovative high-throughput tools that enable rapid assessment of protein stability, aggregation, and folding, accelerating biopharmaceutical development and formulation optimization. High-throughput tools refer to systems capable of performing large numbers of experiments or analyses in parallel, allowing researchers to efficiently generate robust datasets while reducing time and sample consumption. For example, in January 2025, Unchained Labs Ltd., a U.S.-based life sciences tools company, launched Aunty, a platform designed to accelerate biologics and gene therapy research. The system integrates full-spectrum fluorescence with static and dynamic light scattering to simultaneously evaluate thermal, aggregation, and colloidal stability. It operates using minimal sample volumes of approximately 8 µL in a 96-well plate format, enabling efficient, high-throughput protein characterization during early-stage drug development.
In October 2025, Nicoya Lifesciences Inc., a Canada-based life sciences company, acquired Applied Photophysics Inc. for an undisclosed amount. With this acquisition, Nicoya Lifesciences seeks to enhance drug discovery capabilities, expand biophysical analysis offerings, and accelerate the development of innovative therapeutics. Applied Photophysics Inc. is a UK-based company specializing in high-precision biophysical instrumentation for protein characterization and molecular interaction analysis.
Major companies operating in the protein stability screening platforms market are Thermo Fisher Scientific Inc., GE Healthcare Life Sciences, Agilent Technologies Inc., Shimadzu Corporation, Bruker Corporation, Waters Corporation, Revvity Inc., Bio-Rad Laboratories Inc., Spectris plc., Malvern Panalytical Ltd., Promega Corporation, Unchained Labs Inc., NanoTemper Technologies GmbH, Creative Biostructure Inc., BMG LABTECH GmbH, Jasco Inc., Porvair Sciences Ltd., Zinsser Analytic GmbH, Jena Bioscience GmbH, Applied Photophysics Ltd., Enzo Life Sciences Inc.
North America was the largest region in the protein stability screening platforms market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein stability screening platforms market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the protein stability screening platforms market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The protein stability screening platforms market consists of revenues earned by entities by providing services such as thermal stability analysis, aggregation and degradation monitoring, and high-throughput screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The Protein Stability Screening Platforms market also includes sales of Prometheus Panta, Prometheus NT.Plex, and differential scanning calorimeters. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Protein Stability Screening Platforms Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses protein stability screening platforms market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for protein stability screening platforms ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The protein stability screening platforms market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.